Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.1K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.1K
Abnormal Proliferation02:23

Abnormal Proliferation

4.9K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

7.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic modification of the marine-derived yeast Yarrowia lipolytica with high-protein content using a GPI-anchor-fusion expression system.

Biotechnology progress·2009
Same author

Regulation of the Edwardsiella tarda hemolysin gene and luxS by EthR.

Journal of microbiology and biotechnology·2009
Same author

EBV LMP2A-specific T cell immune responses elicited by dendritic cells loaded with LMP2A protein.

Cellular & molecular immunology·2009
Same author

[Combination of volar buttress plate with external fixator for the distal radial fractures of type C3 caused by high-energy injuries].

Zhongguo gu shang = China journal of orthopaedics and traumatology·2009
Same author

Environmental regulation of floral anthocyanin synthesis in Ipomoea purpurea.

Molecular ecology·2009
Same author

PI3K integrates the effects of insulin and leptin on large-conductance Ca2+-activated K+ channels in neuropeptide Y neurons of the hypothalamic arcuate nucleus.

American journal of physiology. Endocrinology and metabolism·2009

Related Experiment Video

Updated: Nov 18, 2025

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

2.9K

MUC16 promotes EOC proliferation by regulating GLUT1 expression.

Fang Wang1, Qing Zhang1, Hailing Zhang1

  • 1Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Journal of Cellular and Molecular Medicine
|February 5, 2021
PubMed
Summary
This summary is machine-generated.

Mucin 16 (MUC16) overexpression promotes epithelial ovarian cancer (EOC) progression by upregulating glucose transporter 1 (GLUT1) expression, increasing glucose uptake and energy for tumor cell proliferation.

Keywords:
epithelial ovarian cancerglucose transporter 1glucose uptakemucin 16proliferation

More Related Videos

Transplantation Into the Mouse Ovarian Fat Pad
09:25

Transplantation Into the Mouse Ovarian Fat Pad

Published on: September 7, 2016

11.7K
Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

12.5K

Related Experiment Videos

Last Updated: Nov 18, 2025

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

2.9K
Transplantation Into the Mouse Ovarian Fat Pad
09:25

Transplantation Into the Mouse Ovarian Fat Pad

Published on: September 7, 2016

11.7K
Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

12.5K

Area of Science:

  • Oncology
  • Biochemistry
  • Molecular Biology

Background:

  • Epithelial ovarian cancer (EOC) is a heterogeneous malignancy with diverse histology and therapeutic responses.
  • Despite advancements, novel therapeutic strategies are crucial for improving EOC patient survival.
  • The precise mechanisms by which mucin 16 (MUC16) promotes tumor progression remain incompletely understood.

Purpose of the Study:

  • To investigate the role of MUC16 in epithelial ovarian cancer (EOC) progression.
  • To elucidate the underlying molecular mechanisms linking MUC16 to tumor growth.
  • To identify potential therapeutic targets for EOC treatment.

Main Methods:

  • Analysis of clinical EOC specimens to correlate MUC16 expression with patient prognosis.
  • In vitro experiments involving MUC16 knockdown in EOC cell lines to assess effects on proliferation.
  • Investigation of the relationship between MUC16 and glucose transporter 1 (GLUT1) expression and glucose uptake.
  • In vivo validation using a tumor-bearing mice model.

Main Results:

  • Overexpression of MUC16 significantly correlates with increased cell proliferation and advanced disease progression in EOC.
  • Patients with high MUC16 expression exhibit a poorer prognosis compared to those with low expression.
  • MUC16 knockdown reduces EOC cell proliferation, mediated by the regulation of GLUT1 expression and subsequent glucose uptake.

Conclusions:

  • MUC16 promotes EOC proliferation and disease progression.
  • This promotion occurs through the MUC16-mediated regulation of GLUT1 expression, enhancing glucose uptake and energy production for tumor cells.
  • MUC16 represents a potential therapeutic target for improving outcomes in epithelial ovarian cancer.